2019
DOI: 10.1007/978-3-030-32281-6_5
|View full text |Cite|
|
Sign up to set email alerts
|

Modeling Disease Progression in Retinal OCTs with Longitudinal Self-supervised Learning

Abstract: Longitudinal imaging is capable of capturing the static anatomical structures and the dynamic changes of the morphology resulting from aging or disease progression. Self-supervised learning allows to learn new representation from available large unlabelled data without any expert knowledge. We propose a deep learning self-supervised approach to model disease progression from longitudinal retinal optical coherence tomography (OCT). Our self-supervised model takes benefit from a generic time-related task, by lea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
26
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 18 publications
(28 citation statements)
references
References 9 publications
2
26
0
Order By: Relevance
“…Apart from robust retinal layer segmentation and the precise spatial differentiation and quantification of retinal fluid compartments, [50][51][52] more refined biomarkers on a subclinical level, such as ellipsoid zone thickness or HRF, and the interaction of these biomarkers can now be explored to assess individual risk in disease progression. 16,[53][54][55][56] The possibilities in AI are continuously expanding and novel, clinically unknown biomarkers can be identified using unsupervised learning. The latter lets the AI algorithm detect retinal markers on its own and evaluates them for the prediction of disease progression, which widely opens the spectrum of pathologic feature detection.…”
Section: Discussionmentioning
confidence: 99%
“…Apart from robust retinal layer segmentation and the precise spatial differentiation and quantification of retinal fluid compartments, [50][51][52] more refined biomarkers on a subclinical level, such as ellipsoid zone thickness or HRF, and the interaction of these biomarkers can now be explored to assess individual risk in disease progression. 16,[53][54][55][56] The possibilities in AI are continuously expanding and novel, clinically unknown biomarkers can be identified using unsupervised learning. The latter lets the AI algorithm detect retinal markers on its own and evaluates them for the prediction of disease progression, which widely opens the spectrum of pathologic feature detection.…”
Section: Discussionmentioning
confidence: 99%
“…The inclusion criteria for studies utilizing learning algorithms for AMD progression were as follows: (i) studies published in the last decade, (ii) use of machine and/or deep learning methods for predictive modeling, (iii) an end point of progression to neovascular AMD or advanced dry AMD, and (iv) the inclusion of imaging data/imaging biomarkers. Of the 15 studies included, 7 used color fundus photos, 12,15,34,36,37,41,43 7 used SD-OCT scans, [23][24][25][38][39][40]42 and 1 used both image modalities 35 as input to ML and DL systems for AMD progression prediction (Table 2). Wu et al, 35 Yim et al, 38 and Burlina et al 41 used imaging only, while others included features representing demographic, environmental, genetics, clinical and temporal characteristics of patients.…”
Section: Machine Learning and Deep Learning Algorithms For Amd Progressionmentioning
confidence: 99%
“…15,23,34,37,43 Of those studies that did report AUC metrics, performance ranged from 0.68 to 0.97 (Table 2). We highlighted six studies that looked at progression to neovascular AMD, 15,[23][24][25]38,40 one that looked at progression to GA only, 39 and eight that included both. 12,[34][35][36][37][41][42][43] Progression predictions at different timepoints were reported, and were as early as three months and up to 12 years (Table 2).…”
Section: Machine Learning and Deep Learning Algorithms For Amd Progressionmentioning
confidence: 99%
See 2 more Smart Citations